ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces Positive Results from Phase 1 Study
|
|
ImagionBio
|
52 |
17K |
8 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
52
|
17K
|
8
|
|
ASX - By Stock
|
IBX Biotech |
Consolidation in effect today
|
|
ImagionBio
|
153 |
58K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
153
|
58K
|
4
|
|
ASX - By Stock
|
IBX Biotech |
EGM recording now available
|
|
ImagionBio
|
17 |
4.6K |
4 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
17
|
4.6K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: 2022 Annual Report to Shareholders
|
|
ImagionBio
|
17 |
5.7K |
6 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
17
|
5.7K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Investor Webinar Participation
|
|
ImagionBio
|
15 |
5.3K |
3 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
15
|
5.3K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Investor Webinar Participation
|
|
ImagionBio
|
15 |
5.3K |
5 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
15
|
5.3K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
ImagionBio
|
186 |
55K |
54 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
186
|
55K
|
54
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
52 |
18K |
15 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
52
|
18K
|
15
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Positive clinical data reported at breast cancer symposium
|
|
ImagionBio
|
110 |
36K |
14 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
110
|
36K
|
14
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Positive clinical data reported at breast cancer symposium
|
|
ImagionBio
|
110 |
36K |
20 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
110
|
36K
|
20
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Prostate cancer research update
|
|
ImagionBio
|
26 |
12K |
42 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
26
|
12K
|
42
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
77 |
24K |
13 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
77
|
24K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Ann: AGM presentation
|
|
ImagionBio
|
35 |
15K |
16 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
35
|
15K
|
16
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
38 |
16K |
20 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
38
|
16K
|
20
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems April 2022 Investor Newsletter
|
|
ImagionBio
|
12 |
7.8K |
13 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
12
|
7.8K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
ImagionBio
|
195 |
79K |
56 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
195
|
79K
|
56
|
|
ASX - By Stock
|
IBX |
Re:
Ann: 2021 Annual Report to Shareholders
|
|
ImagionBio
|
163 |
59K |
40 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
163
|
59K
|
40
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
64 |
20K |
14 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
64
|
20K
|
14
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ImagionBio
|
5.5K |
1.9M |
40 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
40
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems December 2021 Investor Newsletter
|
|
ImagionBio
|
65 |
20K |
22 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
65
|
20K
|
22
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ImagionBio
|
5.5K |
1.9M |
47 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
47
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
96 |
30K |
24 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
96
|
30K
|
24
|
|
ASX - By Stock
|
IBX |
4th site open
|
|
ImagionBio
|
20 |
8.9K |
108 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
20
|
8.9K
|
108
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems September 2021 Investor Newsletter
|
|
ImagionBio
|
42 |
10K |
14 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
42
|
10K
|
14
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ImagionBio
|
5.5K |
1.9M |
22 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
22
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Half-year results release
|
|
ImagionBio
|
25 |
8.8K |
13 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
25
|
8.8K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion to develop nanocrystals for treating breast cancer
|
|
ImagionBio
|
92 |
33K |
87 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
92
|
33K
|
87
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ImagionBio
|
122 |
29K |
9 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
122
|
29K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ImagionBio
|
529 |
183K |
13 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
529
|
183K
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ImagionBio
|
529 |
183K |
72 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
529
|
183K
|
72
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ImagionBio
|
529 |
183K |
31 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
529
|
183K
|
31
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ImagionBio
|
529 |
183K |
54 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
529
|
183K
|
54
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Chairman's Address to Shareholders AGM
|
|
ImagionBio
|
19 |
6.6K |
43 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
19
|
6.6K
|
43
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ImagionBio
|
529 |
183K |
123 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
529
|
183K
|
123
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
ImagionBio
|
155 |
61K |
45 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
155
|
61K
|
45
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion and Patrys collaborate on new cancer imaging agents
|
|
ImagionBio
|
60 |
25K |
52 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
60
|
25K
|
52
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C - quarterly
|
|
ImagionBio
|
224 |
73K |
31 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
224
|
73K
|
31
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems March 2021 Investor Newsletter
|
|
ImagionBio
|
98 |
41K |
60 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
98
|
41K
|
60
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion receives CSIRO grant for prostate cancer project
|
|
ImagionBio
|
33 |
13K |
75 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
33
|
13K
|
75
|
|
ASX - By Stock
|
IBX |
Re:
ANZCTR Trials approved
|
|
ImagionBio
|
60 |
24K |
140 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
60
|
24K
|
140
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems December 2020 Investor Newsletter
|
|
ImagionBio
|
53 |
24K |
68 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
53
|
24K
|
68
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - Study open for enrolment
|
|
ImagionBio
|
157 |
62K |
73 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
157
|
62K
|
73
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C & Quarterly Activity Report
|
|
ImagionBio
|
68 |
16K |
66 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
68
|
16K
|
66
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
ImagionBio
|
213 |
72K |
132 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
213
|
72K
|
132
|
|
ASX - By Stock
|
IBX |
Imagion’s Phase I Study HREC Submission
|
|
ImagionBio
|
26 |
13K |
171 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
26
|
13K
|
171
|
|
ASX - By Stock
|
IBX |
Collaboration with Global Cancer Technology
|
|
ImagionBio
|
33 |
17K |
166 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
33
|
17K
|
166
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Vesting of Performance Rights
|
|
ImagionBio
|
37 |
12K |
80 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
37
|
12K
|
80
|
|